Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- X-rays Indicates Kolla2® Effective in Improving Joint Health in Canine Models
Long-term micro-research finds that after taking Kolla2®, a canine diagnosed with hip Dysplasia resumed its normal mobility, and an X-ray showed normal hip joint cartilage.
- Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support
Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support.
- Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support
Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support.
- Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support
Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support.
- Research Demonstrates Value of Glyco-Flex(R) for Canine Joint Support
Washington State University researchers released results from three studies that strongly suggest that Glyco-Flex III, an animal health product formulated by Vetri-Science Laboratories of Vermont, is a safe and beneficial option for use in dogs requiring joint support.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Study Examines the Effect of Functional Keratin On Equine Lameness
Ten horses with known joint problems leading to lameness were enrolled in a study and provided either Functional Keratin (joint powder) or placebo (1,500 mg) daily. approximately 60 days of the study, lameness improved dramatically in all horses fed keratin and was significantly different compared to placebo.
- Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness
An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets.
- Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness
An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets.
- Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness
An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets.
- Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness
An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets.
- Clinical Study Looks at Herbal Supplements to Address Canine Pain and Lameness
An innovative clinical study at Colorado State University will help veterinarians determine whether or not a herbal supplement can relieve pain experienced by dogs with arthritis. Although the herbal field is gaining much popularity among pet owners, almost no research exists into the benefits and potential dangers of providing these products to pets.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Study Found Adding UC-II to Glucosamine and Chondroitin Also More Effective in Relieving Pain than Glucosamine and Chondroitin Alone
BENICIA, Calif., May 17, 2006 – A new study shows that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. UC-II in combination with glucosamine and chondroitin was also more than twice as effective in reducing pain and increasing joint flexibility and activity than glucosamine and chondroitin alone.
UC-II, a patented ingredient produced by InterHealth Nutraceuticals, Inc., has previously been shown to improve joint flexibility and reduce arthritic symptoms in humans. This new study, conducted on osteoarthritic dogs at Murray State University in Kentucky and presented at the annual meeting of the Society of Toxicology in March 2006 in San Diego, showed that UC-II taken alone reduced overall pain by 62%, while painful limb movement and lameness decreased by 91% and 78%, respectively. UC-II plus glucosamine and chondroitin reduced overall pain in the subjects by 57%, and pain with limb movement and lameness each by 53%, compared to only 24%, 29% and 39%, respectively, in dogs taking the glucosamine and chondroitin combination without UC-II. No adverse effects or changes in liver, heart or kidney functions were observed in any of the animals included in the study.
In addition to the earlier human clinical research, a study published last year in the Journal of Veterinary Pharmacological and Therapeutics showed that UC-II had reduced pain and lameness in arthritic dogs. Furthermore, UC-II improved the overall activity of the dogs. “The results of this new study provide further proof of UC-II’s benefits for anyone seeking relief from joint problems – for themselves or for their companion animals,” said Manashi Bagchi, Ph.D., senior scientist with InterHealth. “And for individuals who may want to include glucosamine and chondroitin in their supplement use, or in supplements for their pets, this study shows that adding UC-II to their daily regimen can make a significant difference in relieving pain and stiffness and improving their quality of life,” she added.
“Manufacturers and retailers now have new options to offer consumers who are looking for a safe and effective product for bone and joint health,” said Paul Dijkstra, executive vice president at InterHealth. “Consumers can enjoy the benefits of UC-II alone or in combination with glucosamine and chondroitin, knowing that they will have an effective product and that neither alternative will produce the serious side effects that often come with prescription products or with over-the-counter pain-relievers such as non-steroidal anti-inflammatory drugs.”
Dijkstra added that UC-II has yet another advantage for health-conscious consumers. “The dosage for UC-II is only 40 mg.,” he said. “For people who may have difficulty in swallowing larger pills, this small size means that even when UC-II is combined with other ingredients the final product will still be of manageable size.”
Strong Market for Natural Bone and Joint Health Products A 2005 consumer survey by the Natural Marketing Institute shows that even relatively young consumers have concerns about bone and joint health, and are willing to consider natural remedies for these problems. Among the general population, 71% are concerned about preventing arthritis or joint disease and 41% say they or a household member is currently managing joint pain or stiffness. And after age 35, arthritis and joint disease is one of six conditions of high concern. Lastly, arthritis and joint disease is the number one condition that consumers say they would treat (68%) or prevent (69%) with supplements.
# # #
About InterHealth Nutraceuticals Inc. InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. In addition to UC-II, the company’s products include Super CitriMax®, ChromeMate®, Aller-7®, OptiBerry®, L-OptiZinc® and Protykin®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at www.InterHealthUSA.com. |